astrazeneca glp-1 launches combo to treat obesity co-morbidities Latin America Glucagon-like Peptide-1 Agonists

Although first approved for clinical use in 2005, it was not until 2023, following an exponential increase in their use, that a number of case reports of pulmonary aspiration despite adequate fasting called attention to their potential impact on perioperative patient safety

placebo, glutamate (MSG) was only demonstrated to be a direct trigger of anxiety symptoms, and only in those with more severe anxiety

GLP-1 receptor agonists can mitigate that risk in a number of ways, including supporting healthier blood pressure and weight loss

But taking certain supplements may be helpful in specific situations

B12 Shots & B12 Injections: Navigating the Spectrum From Benefits to Coping with Severe Symptoms